Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis

References

• Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;58:26-35
   PubMed Web of Science ®Google Scholar
• World Health Organization. Disease incidence, prevalence, and disability. The Global Burden of Disease 2004 (accessed 3 Dec 2010). World Health Organization. Available at: www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_part3.pdf. Accessed December 3, 2010
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Prevalence and most common causes of disability among adults—United States, 2005. MMWR Morb Mortal Wkly Rep 2009;58:421-6
   PubMedGoogle Scholar
• Murray CJL, Lopez AD. The global burden of disease: a comprehensive assessment of the mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. ed. Boston: Harvard School of Public Health on behalf of the World Health Organization, and the World Bank, 1996
   Google Scholar
• Lohmander LS, Gerhardsson de Verdier M, Rollof J, et al. Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass: a population-based prospective cohort study. Ann Rheum Dis 2009;68:490-6
   PubMed Web of Science ®Google Scholar
• Cooper C, Snow S, McAlindon TE, et al. Risk factors for the incidence and progression of radiographic knee osteoarthritis. Arthritis Rheum 2000;43:995-1000
   PubMed Web of Science ®Google Scholar
• Leardini G, Salaffi F, Caporali R, et al. Direct and indirect costs of osteoarthritis of the knee. Clin Exp Rheumatol 2004;22:699-706
   PubMed Web of Science ®Google Scholar
• Rabenda V, Manette C, Lemmens R, et al. Direct and indirect costs attributable to osteoarthritis in active subjects. J Rheumatol 2006;33:1152-8
   PubMed Web of Science ®Google Scholar
• Gupta S, Hawker GA, Laporte A, et al. The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition. Rheumatology (Oxford) 2005;44:1531-7
   PubMed Web of Science ®Google Scholar
• Gabriel SE, Crowson CS, Campion ME, et al. Direct medical costs unique to people with arthritis. J Rheumatol 1997;24:719-25
   PubMed Web of Science ®Google Scholar
• Dunn JD, Pill MW. A claims-based view of health care charges and utilization for commercially insured patients with osteoarthritis. Manag Care 2009;18:44-50
   PubMedGoogle Scholar
• American College of Rheumatology. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43:1905-15
   PubMed Web of Science ®Google Scholar
• Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16:137-62
   PubMed Web of Science ®Google Scholar
• Reilly MCZ, AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993;4:353-65
   PubMedGoogle Scholar
• Stockl K, Cyprien L, Chang EY. Gastrointestinal bleeding rates among managed care patients newly started on cox-2 inhibitors or nonselective NSAIDs. J Manag Care Pharm 2005;11:550-8
   PubMedGoogle Scholar
• Joshi GP, Gertler R, Fricker R. Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs. Anesth Analg 2007;105:1793-804
   PubMed Web of Science ®Google Scholar
• Straube S, Tramèr MR, Moore RA, et al. Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use. BMC Gastroenterol 2009;9:41
   PubMedGoogle Scholar
• Avouac J, Gossec L, Dougados M. Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 2007;15:957-65
   PubMed Web of Science ®Google Scholar
• Fishbain DA, Cole B, Lewis JE, et al. Do opioids induce hyperalgesia in humans? An evidence-based structured review. Pain Med 2009;10:829-39
   PubMed Web of Science ®Google Scholar
• Nwokeji ED, Rascati KL, Brown CM, et al. Influences of attitudes on family physicians’ willingness to prescribe long-acting opioid analgesics for patients with chronic nonmalignant pain. Clin Ther 2007;29(Suppl):2589-602
   PubMed Web of Science ®Google Scholar
• Wolfert MZ, Gilson AM, Dahl JL, et al. Opioid analgesics for pain control: Wisconsin physicians’ knowledge, beliefs, attitudes, and prescribing practices. Pain Med 2010;11:425-34
   PubMed Web of Science ®Google Scholar
• Breuer B, Cruciani R, Portenoy RK. Pain management by primary care physicians, pain physicians, chiropractors, and acupuncturists: a national survey. South Med J 2010;103:738-47
   PubMed Web of Science ®Google Scholar
• Jamison RN, Anderson KO, Peeters-Asdourian C, et al. Survey of opioid use in chronic nonmalignant pain patients. Reg Anesth 1994;19:225-30
   PubMedGoogle Scholar
• Donner B, Raber M, Zenz M, et al. Experiences with the prescription of opioids: a patient questionnaire. J Pain Symptom Manage 1998;15:231-4
   PubMed Web of Science ®Google Scholar
• Weinstein SM, Laux LF, Thornby JI, et al. Physicians’ attitudes toward pain and the use of opioid analgesics: results of a survey from the Texas Cancer Pain Initiative. South Med J 2000;93:479-87
   PubMed Web of Science ®Google Scholar
• Turk DC, Brody MC, Okifuji EA. Physicians’ attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain. Pain 1994;59:201-8
   PubMed Web of Science ®Google Scholar
• Bhamb B, Brown D, Hariharan J, et al. Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin 2006;22:1859-65
   PubMed Web of Science ®Google Scholar
• McKracken LM, Hoskins J, Eccleston C. Concerns about medication and medication use in chronic pain. J Pain 2006;7:726-34
   PubMedGoogle Scholar
• Gabriel SE, Crowson CS, Campion ME, et al. Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls. J Rheumatol 1997;24:43-8
   PubMed Web of Science ®Google Scholar
• Le Pen C, Reygrobellet C, Gerentes I. Financial cost of osteoarthritis in France. The “COART” France study. Joint Bone Spine 2005;72:567-70
   PubMed Web of Science ®Google Scholar
• Grotle M, Hagen KB, Natvig B, et al. Prevalence and burden of osteoarthritis: results from a population survey in Norway. J Rheumatol 2008;35:677-84
   PubMed Web of Science ®Google Scholar
• White AG, Birnbaum HG, Janagap CC, et al. Direct and indirect costs of pain therapy for osteoarthritis in an insured population in the United States. J Occup Environ Med 2008;50:998-1005
   PubMed Web of Science ®Google Scholar
• Simon L, Lipman A, Jacox A, et al. Guideline for the Management of Pain in Osteoarthritis, Rheumatoid Arthritis, and Juvenile Chronic Arthritis. Glenview, IL: American Pain Society; 2002
   Google Scholar
• van Dijk GM, Veenhof C, Schellevis F, et al. Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or knee. BMC Musculoskelet Disord 2008;9:95
   PubMed Web of Science ®Google Scholar
• Chan KW, Ngai HY, Ip KK, et al. Co-morbidities of patients with knee osteoarthritis. Hong Kong Med J 2009;15:168-72
   PubMedGoogle Scholar
• Hochberg MC. Mortality in osteoarthritis. Clin Exp Rheumatol 2008;5 Suppl 51:S120-4
   Google Scholar
• Pereira RM, de Carvalho JF, Bonfa E. Metabolic syndrome in rheumatological diseases. Autoimmun Rev 2009;8:415-19
   PubMed Web of Science ®Google Scholar
• Engstrom G, Gerhardsson de Verdier M, Rollof J, et al. C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study. Osteoarthritis Cartilage 2009;17:168-73
   PubMed Web of Science ®Google Scholar
• Wilcox S, Brenes GA, Levine D, et al. Factors related to sleep disturbance in older adults experiencing knee pain or knee pain with radiographic evidence of knee osteoarthritis. J Am Geriatr Soc 2000;48:1241-51
   PubMed Web of Science ®Google Scholar
• Allen KD, Renner JB, Devellis B, et al. Osteoarthritis and sleep: the Johnston County Osteoarthritis Project. J Rheumatol 2008;35:1102-7
   PubMed Web of Science ®Google Scholar
• Scopaz KA, Piva SR, Wisniewski S, et al. Relationships of fear, anxiety, and depression with physical function in patients with knee osteoarthritis. Arch Phys Med Rehabil 2009;90:1866-73
   PubMed Web of Science ®Google Scholar
• McCracken LM, Iverson GL. Disrupted sleep patterns and daily functioning in patients with chronic pain. Pain Res Manag 2002;7:75-9
   PubMedGoogle Scholar
• Smith MT, Haythornthwaite JA. How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med Rev 2004;8:119-32
   PubMed Web of Science ®Google Scholar
• Bigatti SM, Hernandez AM, Cronan TA, et al. Sleep disturbances in fibromyalgia syndrome: Relationship to pain and depression. Arthritis Rheum 2008;59:961-7
   PubMed Web of Science ®Google Scholar
• Smith MT, Quartana PJ, Okonkwo RM, et al. Mechanisms by which sleep disturbance contributes to osteoarthritis pain: a conceptual model. Curr Pain Headache Rep 2009;13:447-54
   PubMed Web of Science ®Google Scholar
• Geisser ME, Roth RS, Theisen ME, et al. Negative affect, self-report of depressive symptoms, and clinical depression: relation to the experience of chronic pain. Clin J Pain 2000;16:110-20
   PubMed Web of Science ®Google Scholar
• Schieir O, Thombs BD, Hudson M, et al. Symptoms of depression predict the trajectory of pain among patients with early inflammatory arthritis: a path analysis approach to assessing change. J Rheumatol 2009;36:231-9
   PubMed Web of Science ®Google Scholar
• Manias E, Claydon-Platt K, McColl GJ, et al. Managing complex medication regimens: perspectives of consumers with osteoarthritis and healthcare professionals. Ann Pharmacother 2007;41:764-71
   PubMed Web of Science ®Google Scholar
• Mapel DW, Shainline M, Paez K, et al. Hospital, pharmacy, and outpatient costs for osteoarthritis and chronic back pain. J Rheumatol 2004;31:573-83
   PubMed Web of Science ®Google Scholar
• Johnson TJ, Stahl-Moncada S. Medicaid prescription formulary restrictions and arthritis treatment costs. Am J Public Health 2008;98:1300-5
   PubMed Web of Science ®Google Scholar
• Kleinman N, Harnett J, Melkonian A, et al. Burden of fibromyalgia and comparisons with osteoarthritis in the workforce. J Occup Environ Med 2009;51:1384-93
   PubMed Web of Science ®Google Scholar
• White LA, Birnbaum HG, Kaltenboeck A, et al. Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med 2008;50:13-24
   PubMed Web of Science ®Google Scholar
• Zhang W, Gignac MA, Beaton D, et al. Productivity loss due to presenteeism among patients with arthritis: estimates from 4 instruments. J Rheumatol 2010;37:1805-14
   PubMed Web of Science ®Google Scholar
• Kotlarz H, Gunnarsson CL, Fang H, et al. Osteoarthritis and absenteeism costs: evidence from US National Survey Data. J Occup Environ Med 2010;52:263-8
   PubMed Web of Science ®Google Scholar